Consolidated Statements of Operations (USD $)	12 Months Ended		74 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011
REVENUES
COST AND EXPENSES
Research and Development	51,286	416,828	1,255,171
General and Administrative	550,769	1,133,969	6,105,822
Depreciation and Amortization			2,668
Consulting and Professional Fees	63,692	116,632	4,810,714
Impairment of Goodwill and Intangibles			34,688
Total Costs and Expenses	665,747	1,667,429	12,209,063
OPERATING LOSS	(655,747)	(1,667,429)	(12,209,063)
OTHER INCOME & (EXPENSES)
Interest Expense	(62,829)	(91,278)	(358,535)
Interest Income			306
Other Income	146,791		176,891
Gain on de-consolidation of subsidiary	42,182,649		42,182,649
Loss on sale of Available for Sale Securities			(487,900)
Loss on disposal of Equipment	(510,782)		(510,782)
Other Expense			(166)
Other Losses attributable to subsidiary	(228,713)		(228,713)
Total Other Income & (Expense)	41,527,116	(91,278)	40,733,750
NET INCOME (LOSS) before subsidiary losses	40,861,369	(1,758,707)	28,564,687
(Net Income) Loss attributable to noncontrolling interest	229,845	213,121	536,961
NET INCOME (LOSS) before equity in subsidiary losses	41,091,214	(1,545,586)	29,101,648
Equity in Net Income (Loss) of subsidiary	(264,567)		(264,567)
NET INCOME (LOSS) available to common shareholders	$ 40,826,647	$ (1,545,586)	$ 28,837,081
BASIC EARNINGS (LOSS) PER SHARE	$ 0.57	$ (0.03)
FULLY DILUTED EARNINGS (LOSS) PER SHARE	$ 0.57
Weighted average number of shares outstanding	71,504,816	59,073,798
Fully Diluted weighted average number of shares outstanding	72,071,414